Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > ME 23andMe > Detailed Quotes

ME 23andMe

2.860
-0.130-4.35%
Close 09/30 16:00 ET
2.910
+0.050+1.75%
Post Mkt Price 09/30 18:54 ET
High
3.060
Open
2.990
Turnover
7.98M
Low
2.850
Pre Close
2.990
Volume
2.73M
Market Cap
1.29B
P/E(TTM)
Loss
52wk High
13.680
Shares
451.52M
P/E(Static)
Loss
52wk Low
2.120
Float Cap
804.00M
Bid/Ask %
-81.82%
Historical High
18.160
Shs Float
281.12M
Volume Ratio
0.66
Historical Low
2.120
Dividend TTM
--
Div Yield TTM
--
P/B
1.51
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.97%
Amplitude
7.02%
Avg Price
2.921
Lot Size
1
Float Cap
804.00M
Bid/Ask %
-81.82%
Historical High
18.160
Shs Float
281.12M
Volume Ratio
0.66
Historical Low
2.120
Dividend TTM
--
P/B
1.51
Dividend LFY
--
Turnover Ratio
0.97%
Amplitude
7.02%
Avg Price
2.921
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
23andMe Holding Co. is consumer genetics and research company, which engages to help people access, understand, and benefit from the human genome. It provides direct access to genetic information with multiple Food and Drug Administration authorizations for genetic health risk reports. The company operates under the Consumer and Research Services segment, and the Therapeutics segment. The firm’s research platform has generated publications on the genetic underpinnings of a range of diseases, conditions, and traits. The platform also powers the 23andMe therapeutics group, pursuing drug discovery programs rooted in human genetics across a spectrum of disease areas, including oncology, respiratory, and cardiovascular diseases, in addition to other therapeutic areas. The company was founded by Anne E. Wojcickiin 2006 and is headquartered in South San Francisco, CA.
CEO: Ms. Anne Wojcicki
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...